Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2012
07/05/2012CA2823194A1 Therapeutic and diagnostic methods involving biglycan and utrophin
07/05/2012CA2823066A1 Compositions comprising natriuretic peptides and methods of use thereof
07/05/2012CA2823018A1 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
07/05/2012CA2823010A1 Use of nutritional compositions including lactoferrin in stimulating immune cells
07/05/2012CA2822892A1 Method for inhibiting pathogens using a nutritional composition
07/05/2012CA2822207A1 Oxidosqualene cyclase as a protein target for anticancer therapeutics
07/05/2012CA2822114A1 Sirna against cbl-b and optionally il-2 and il-12 for use in the treatment of cancer
07/04/2012EP2471907A2 Placental stem cell populations
07/04/2012EP2471906A2 Placental stem cell populations
07/04/2012EP2471905A2 Placental stem cell populations
07/04/2012EP2471904A2 Placental stem cell populations
07/04/2012EP2471815A1 Proteins, nucleic acids encoding the same and associated methods of use
07/04/2012EP2471811A1 Oxyntomodulin derivatives
07/04/2012EP2471810A1 Oxyntomodulin derivatives
07/04/2012EP2471809A1 Proteins, nucleic acids encoding the same and associated methods of use
07/04/2012EP2471807A1 Long-acting polypeptides and methods of producing and administering same
07/04/2012EP2471806A2 Cyclosporine derivates
07/04/2012EP2471555A2 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
07/04/2012EP2471548A1 siRNA against Cbl-b and optionally IL2 and IL12 for use in the treatment of cancer
07/04/2012EP2471547A1 Apoptosis inducer
07/04/2012EP2471546A1 Therapeutic agent for rhinitis
07/04/2012EP2471527A2 Facially amphiphillc polymers and oligomers and uses thereof
07/04/2012EP2471526A2 Facially amphiphillic polymers and oligomers and uses thereof
07/04/2012EP2471525A2 Facially amphiphllic polymers and oligomers and uses thereof
07/04/2012EP2471524A2 Facially amphiphllic polymers and oligomers and uses thereof
07/04/2012EP2471518A2 Composition comprising oil drops
07/04/2012EP2471510A1 Liquid formulation of G-CSF
07/04/2012EP2471380A2 Animal feeds and veterinary compositions
07/04/2012EP2471379A2 Treatment of ectoparasitic infestation
07/04/2012EP2470909A2 Adam12 inhibitors and their use against inflammation-induced fibrosis
07/04/2012EP2470670A1 Coagulation factor vii compositions and methods of making and using same
07/04/2012EP2470658A1 Apolipoprotein l- i variants and their use
07/04/2012EP2470651A1 Lung and esophageal cancer related gene adamts18
07/04/2012EP2470648A1 New endolysin obpgplys
07/04/2012EP2470561A1 Targeting tissue factor to activated platelets
07/04/2012EP2470559A1 Coagulation factor ix compositions and methods of making and using same
07/04/2012EP2470217A1 Targeting pax2 for the treatment of breast cancer
07/04/2012EP2470212A1 Method of treatment of philadelphia chromosome positive leukaemia
07/04/2012EP2470199A2 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
07/04/2012EP2470198A2 Glucagon-like peptide-1 receptor (glp-1r) agonists for treating autoimmune disorders
07/04/2012EP2470197A1 Compositions for absorption and sustained action of leptin-related peptides
07/04/2012EP2470196A1 Osteolysis treatment
07/04/2012EP2470195A1 Il-17 for use in treating local infections in mammals
07/04/2012EP2470194A1 Novel nucleoside phosphonates and analogs
07/04/2012EP2470193A1 Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates
07/04/2012EP2470192A1 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins
07/04/2012EP2470191A1 Methods and compositions for preventing or treating ophthalmic conditions
07/04/2012EP2470190A1 Echinocandin derivatives
07/04/2012EP2470189A1 Processes for preparing protease inhibitors of hepatitis c virus
07/04/2012EP2470010A1 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
07/04/2012EP2326341B1 Oxytocin formulations and uses thereof
07/04/2012EP2285416B1 Conjugates for the treatment of mesothelioma
07/04/2012EP2276725B1 New ruthenium complexes as catalysts for metathesis reactions
07/04/2012EP2178888B1 Proteasome inhibitors
07/04/2012EP2167534B1 Bioactive peptides and method of using same
07/04/2012EP1945256B1 Methods and compositions for improving wound repair
07/04/2012EP1883699B1 Non-viral vector system for transporting nucleic acid into the lungs
07/04/2012EP1758610B1 Methods of treating cancer using il-21 and monoclonal antibody therapy
07/04/2012EP1556410B1 Peptide fragments of the harp factor inhibiting angiogenesis
07/04/2012CN1964736B Dalbavancin compositions for treatment of bacterial infections
07/04/2012CN1829738B Novel insulin derivatives
07/04/2012CN1812808B Stabilized pharmaceutical peptide compositions
07/04/2012CN1733798B Hepatitis B virus surface L protein related peptide
07/04/2012CN1680443B Recombinat protein containing albumin multimer
07/04/2012CN102549011A Pharmaceutical preparation comprising recombinant HCG
07/04/2012CN102548617A Bmp-alk3 antagonists and uses for promoting bone growth
07/04/2012CN102548583A Prodrugs comprising an insulin linker conjugate
07/04/2012CN102548576A Methods for assessing tophus response during urate lowering therapy in treatment tophaceous gout
07/04/2012CN102548575A Eye drops
07/04/2012CN102548574A Novel NPR-B agonists
07/04/2012CN102548573A Use of NKG2D inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes
07/04/2012CN102548572A Vaccines and compositions against streptococcus pneumoniae
07/04/2012CN102548399A Use of melanocortins to treat dyslipidemia
07/04/2012CN102533918A Method for preparing rapeseed active polypeptides
07/04/2012CN102533917A Method for preparing RGD (arginine glycine aspartate) active polypeptide from collagen
07/04/2012CN102533787A Peganum harmala lipid transfer protein gene, and recombination expression and application thereof
07/04/2012CN102533702A Antidotes for factor XA inhibitors and methods of using the same
07/04/2012CN102533686A Method for preparing antioxidant
07/04/2012CN102533655A CHO-S cell strain for efficient expression type human recombinant protein GLP1/Fc and establishment method thereof
07/04/2012CN102532326A Tumor-targeted plasminogen Kringle5 variant and application thereof
07/04/2012CN102532325A Method for preparing cecropins AD and frog Buforin II fusion antimicrobial peptide by using hydroxylamine cutting method, and uses thereof
07/04/2012CN102532323A Polypeptide complex, pharmaceutical composition, as well as preparation method and application of polypeptide complex
07/04/2012CN102532305A Protease inhibitor BmSPI38 and preparation method and application thereof
07/04/2012CN102532303A Synthesis and application of exenatide joined with polyethylene glycol
07/04/2012CN102532301A Novel Exendin-4 analogues and preparation method thereof
07/04/2012CN102532300A Interferon alpha mutant and polyethylene glycol derivative thereof
07/04/2012CN102532299A Interferon alpha mutant and polyethylene glycol derivative thereof
07/04/2012CN102532297A Ancylostoma caninum anticoagulant peptide and preparation and application thereof
07/04/2012CN102532276A Cyclohexapeptide antibacterial compounds and preparation method thereof
07/04/2012CN102532269A Dominant sequence of delta 1 chain complementary determining region (CDR) 3 in gamma delta T lymphocytes, and T cell receptor (TCR) transfected cells and application thereof
07/04/2012CN102532268A Oligopeptide with breast cancer resistant activity and application thereof
07/04/2012CN102532265A Gramicidin, isomer thereof and application thereof
07/04/2012CN102532264A Peptide-based compounds
07/04/2012CN102532261A Bone remodeling activator-typrotide and medicament composition and application thereof
07/04/2012CN102532260A Silkworm chrysalis protein source dipeptide DA and uses thereof
07/04/2012CN102532198A Antiviral phosphinate compounds
07/04/2012CN102532051A 有丝分裂驱动蛋白抑制剂及其使用方法 Mitotic kinesin inhibitors and methods of use
07/04/2012CN102526796A Absorbable haemostatic material prepared based on rat tail collagen and preparation method of same
07/04/2012CN102526761A DNA vaccine for treating hepatic fibrosis caused by Schistosomiasis japonica and application thereof
07/04/2012CN102526758A Stable aqueous solution of pegylation interferon
1 ... 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 ... 3163